Generic Name and Formulations:
Nitroglycerin 2% (15mg/inch); oint; contains lanolin.
Indications for NITRO-BID:
Prophylaxis of angina. Not for acute attacks.
Apply, using applicator, usually to the chest and occlude. Initially ½ inch on awakening and then 6 hrs later; may increase to 1 inch, then to 2 inches twice daily.
Acute MI. CHF. Hypotension. Volume depleted. Hypertrophic cardiomyopathy. Avoid abrupt cessation. Elderly. Pregnancy (Cat.C). Nursing mothers.
See Contraindications. Severe hypotension with sildenafil. Vasodilating effects potentiated with alcohol, other vasodilators. Orthostatic hypotension with calcium channel blockers.
Headache, dizziness, flushing, orthostatic hypotension, rash; syncope, methemoglobinemia (rare).
Oint—30g, 60g (w. applicator); Oint—48 x 1g packets
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Pharmacologically Induced Headache Accompanied by Dilated Cephalic Vessels
- IV Lidocaine May Be Safe, Efficacious for Pediatric Status Migraine
- Gray Matter Changes in Migraine Associated With Clinical Characteristics